|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,310,000,000 |
Market
Cap: |
78.89(B) |
Last
Volume: |
11,690,725 |
Avg
Vol: |
7,834,076 |
52
Week Range: |
$53.63 - $81.42 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Retail |
Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : 10.7 |
Insider 6 Months : 10.7 |
Insider 3/6 Months : 21.5 |
|
Guru Rank Number : 214 |
Guru Rank Value : 5.7 |
Guru Occurances : 5 |
|
|
|
|
|
|
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
10,181 |
10,181 |
12,181 |
26,181 |
Total Buy Value |
$554,173 |
$554,173 |
$695,103 |
$1,671,670 |
Total People Bought |
2 |
2 |
2 |
3 |
Total Buy Transactions |
2 |
2 |
3 |
4 |
Total Shares Sold |
0 |
29,473 |
55,232 |
484,338 |
Total Sell Value |
$0 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
Total People Sold |
0 |
1 |
2 |
5 |
Total Sell Transactions |
0 |
1 |
2 |
7 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mahoney Michael F |
Director |
|
2024-05-02 |
4 |
B |
$54.49 |
$500,294 |
D/D |
9,181 |
9,356 |
2.39 |
11% |
|
Ludwig Edward J |
Director |
|
2024-05-02 |
4 |
B |
$53.88 |
$53,879 |
D/D |
1,000 |
21,630 |
2.39 |
11% |
|
Joyner J. David |
EVP&President-PharmacyServices |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,280 |
44,241 |
|
- |
|
Rohan Karen |
President and CEO |
|
2024-04-01 |
4 |
D |
$79.56 |
$4,928,981 |
D/D |
(61,953) |
74,687 |
|
- |
|
Rohan Karen |
President and CEO |
|
2024-04-01 |
4 |
A |
$79.56 |
$3,599,931 |
D/D |
45,248 |
45,248 |
|
- |
|
Kane Brian A |
EVP/President, Aetna |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,569 |
12,569 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2024-04-01 |
4 |
A |
$79.56 |
$849,939 |
D/D |
10,683 |
15,109 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2024-04-01 |
4 |
D |
$79.56 |
$238,998 |
D/D |
(3,004) |
8,480 |
|
- |
|
Cowhey Thomas F. |
EVP and CFO |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,082 |
47,995 |
|
- |
|
Cowhey Thomas F. |
EVP and CFO |
|
2024-04-01 |
4 |
D |
$79.56 |
$136,764 |
D/D |
(1,719) |
35,642 |
|
- |
|
Shah Prem S |
EVP and Pres-Pharm, Consumer W |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,082 |
37,057 |
|
- |
|
Shah Prem S |
EVP and Pres-Pharm, Consumer W |
|
2024-04-01 |
4 |
D |
$79.56 |
$627,888 |
D/D |
(7,892) |
42,034 |
|
- |
|
Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
|
2024-04-01 |
4 |
A |
$79.56 |
$549,998 |
D/D |
6,913 |
23,666 |
|
- |
|
Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
|
2024-04-01 |
4 |
D |
$79.56 |
$182,829 |
D/D |
(2,298) |
11,212 |
|
- |
|
Mandadi Tilak |
EVP, Chief Technology Officer |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,339 |
82,904 |
|
- |
|
Khichi Samrat S. |
EVP, CPO and General Counsel |
|
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,569 |
44,490 |
|
- |
|
Havanec Laurie P. |
EVP and Chief People Officer |
|
2024-04-01 |
4 |
A |
$79.56 |
$749,933 |
D/D |
9,426 |
9,426 |
|
- |
|
Havanec Laurie P. |
EVP and Chief People Officer |
|
2024-04-01 |
4 |
D |
$79.56 |
$607,043 |
D/D |
(7,630) |
37,553 |
|
- |
|
Joyner J. David |
EVP&President-PharmacyServices |
|
2024-02-28 |
4 |
D |
$75.19 |
$148,124 |
D/D |
(1,970) |
40,681 |
|
- |
|
Khichi Samrat S. |
EVP, CPO and General Counsel |
|
2024-02-28 |
4 |
D |
$75.19 |
$466,930 |
D/D |
(6,210) |
9,750 |
|
- |
|
Cowhey Thomas F. |
SVP, Interim CFO |
|
2024-02-28 |
4 |
D |
$75.19 |
$424,147 |
D/D |
(5,641) |
28,631 |
|
- |
|
Havanec Laurie P. |
EVP and Chief People Officer |
|
2024-02-26 |
4 |
D |
$76.43 |
$511,928 |
D/D |
(6,698) |
45,183 |
|
- |
|
Shah Prem S |
EVP and Pres-Pharm, Consumer W |
|
2024-02-26 |
4 |
D |
$76.43 |
$19,948 |
D/D |
(261) |
43,185 |
|
- |
|
Chaguturu Sreekanth K |
EVP and Chief Medical Officer |
|
2024-02-26 |
4 |
D |
$76.43 |
$27,133 |
D/D |
(355) |
9,334 |
|
- |
|
Shah Prem S |
EVP and Pres-Pharm, Consumer W |
|
2024-02-16 |
4 |
S |
$76.95 |
$2,267,947 |
D/D |
(29,473) |
39,765 |
|
21% |
|
101 Records found
|
|
Page 1 of 5 |
|
|